Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
TCF1
100%
T-cell Leukemia/lymphoma
100%
Beta-catenin
100%
Genomic Instability
36%
Lymphoma
27%
TCR Signaling
27%
Molecular Mechanism
18%
Oncogenic Translocations
18%
Topological Proximity
18%
T Cells
18%
Deregulation
18%
DNA Repair
18%
Genome Integrity
18%
Activity Change
9%
Inherent Characteristics
9%
C-Myc
9%
Rule Components
9%
Multiple Stages
9%
DNA-binding Proteins
9%
Wnt Signaling
9%
Tumor Progression
9%
Human Leukemia
9%
Molecular Components
9%
Chromosomal Translocation
9%
T-cell Leukemia
9%
Binding Site
9%
Chromatin Remodelers
9%
Human Disease
9%
RAG2
9%
Chromatin Landscape
9%
Cancer Model
9%
Illegitimate Recombination
9%
Genomically Unstable
9%
Wnt Signaling Pathway
9%
Conditional Ablation
9%
Resistance to Therapy
9%
T-cell Lymphoma
9%
T Cell Development
9%
Lymphomagenesis
9%
In Cancer
9%
Recombinase
9%
ChIP-seq Analysis
9%
Tumor Resistance
9%
DNA Recombination
9%
Governing Rules
9%
Repair Proteins
9%
DNA Damage
9%
Thymocytes
9%
Pten
9%
Molecular Processes
9%
Recombination Repair
9%
Mouse Model
9%
Recombination Protein
9%
Double-stranded DNA (dsDNA)
9%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Catenin
100%
T Cell Receptor
45%
Genome Instability
36%
Carcinogenesis
18%
Molecular Mechanism
18%
Wnt Signaling Pathway
18%
DNA Repair
18%
Myc
18%
Genomics
9%
Binding Site
9%
RAG2
9%
Tumor Progression
9%
Cell Maturation
9%
DNA Recombination
9%
Recombination Repair
9%
Recombinase
9%
Oncogene C Myc
9%
Protein Kinase B
9%
Mouse Model
9%
Chromosomal Translocation
9%
Thymocyte
9%
Chromatin
9%
DNA-binding Protein
9%
Cancer Model
9%
Chromatin Remodeling
9%